US Stock Futures Flat; All Eyes On Fed Minutes

Loading...
Loading...
Pre-open movers
US stock futures traded mostly flat in early pre-market trade. The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET. Futures for the Dow Jones Industrial Average dropped 5 points to 16,855.00, while the Standard & Poor's 500 index futures rose 0.30 points to 1,960.70. Futures for the Nasdaq 100 index gained 2 points to 3,865.25.
A Peek Into Global Markets
European markets were lower today, with the Spanish Ibex Index dropping 0.06%, STOXX Europe 600 Index declining 0.31%. German DAX 30 index fell 0.04%, French CAC 40 Index declined 0.07% and London's FTSE 100 Index dropped 0.56%. In Asian markets, Japan's Nikkei Stock Average fell 0.08%, Hong Kong's Hang Seng Index declined 1.55%, China's Shanghai Composite Index tumbled 1.23% and India's BSE Sensex dipped 0.54%. China's consumer price index rose 2.3% y/y in June, while the producer price index declined 1.1% y/y in June.
Broker Recommendation
Analysts at HSBC upgraded Schlumberger NV
SLB
from “neutral” to “overweight.” The target price for Schlumberger has been raised from $105 to $135. Schlumberger's shares closed at $116.75 yesterday.
Breaking news
  • Michael Kors KORS is pleased to announce that Mark Brashear has been named to the newly created role of President of Men's. To read the full news, click here.
  • Lexicon Pharmaceuticals LXRX announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, will provide funding to support a Phase 2, randomized, double-masked, placebo-controlled clinical trial to evaluate the efficacy and safety of LX4211 in a younger population with T1D. To read the full news, click here.
  • Boeing BA is enhancing its support to customers in Southeast Asia through a joint venture in Singapore with SIA Engineering Company SEGSF. To read the full news, click here.
  • Ultragenyx Pharmaceutical RARE today announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. To read the full news, click here.
Loading...
Loading...
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsBiotechnologyFederal Open Market CommitteeHealth CareHSBCUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...